Relationship between symptoms, subjective well-being and medication use in gastro-oesophageal reflux disease
Authors:
Open Access
- 22 June 2007
- journal article
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 61 (8) , 1301-1307
Abstract
To report data from a multinational survey investigating the relationship between gastro-oesophageal reflux disease (GERD) symptoms, treatment and subjective well-being. Patients formally diagnosed with GERD (n = 929) and undiagnosed subjects with symptoms suggestive of GERD (n = 924) were included. Sixty per cent of diagnosed (mean age: 51.7 years) and 54% of undiagnosed (mean age: 44.3 years) participants were female. Over 50% of participants were overweight or obese. Most respondents consumed alcohol, and one-third were smokers. In total, 78% of diagnosed subjects were currently receiving medication prescribed by their doctor, and 65% were taking over-the-counter (OTC) treatments. The majority (97%) of undiagnosed subjects were taking OTC medication, the most common of which were antacids (78%). Despite medication, 58% of diagnosed and 73% of undiagnosed subjects still experienced GERD symptoms some of the time. Approximately one-third of subjects in each group reported that they ate less than usual, felt generally unwell, were tired/worn out or worried/fearful for the majority of the time because of their GERD symptoms, and around half reported decreased well-being, including reduced work or leisure time productivity. These findings attest to the severity and impact of GERD symptoms, highlighting the need to improve the management of GERD in routine practice. Many symptomatic and long-term sufferers, for example, may benefit from taking steps towards a healthier lifestyle (e.g. weight reduction) in addition to optimisation of acid-suppressive therapy.Keywords
This publication has 12 references indexed in Scilit:
- The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based ConsensusAmerican Journal of Gastroenterology, 2006
- Does the treatment of gastroesophageal reflux disease (GERD) meet patients’ needs? A survey‐based studyCurrent Medical Research and Opinion, 2006
- Gastroesophageal Reflux Symptoms and Well-Being in a Random Sample of the General Population of a Swedish CommunityAmerican Journal of Gastroenterology, 2006
- Systematic review: proton‐pump inhibitor failure in gastro‐oesophageal reflux disease – where next?Alimentary Pharmacology & Therapeutics, 2005
- Epidemiology of gastro-oesophageal reflux disease: a systematic reviewGut, 2005
- Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux DiseaseAmerican Journal of Gastroenterology, 2005
- Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptomsEuropean Journal of Clinical Pharmacology, 2004
- Review of the Quality of Life and Burden of Illness in Gastroesophageal Reflux DiseaseDigestive Diseases, 2004
- Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas refluxGut, 2004
- Gastric Acid Control With Esomeprazole, Lansoprazole, Omeprazole, Pantoprazole, and Rabeprazole: A Five-Way Crossover StudyAmerican Journal of Gastroenterology, 2003